BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ, Wilson SD, Pitt HA. Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg. 2005;241:776-783; discussion 783-785. [PMID: 15849513 DOI: 10.1097/01.sla.0000161981.58631.ab] [Cited by in Crossref: 250] [Cited by in F6Publishing: 213] [Article Influence: 14.7] [Reference Citation Analysis]
Number Citing Articles
1 Franko J, Feng W, Yip L, Genovese E, Moser AJ. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg. 2010;14:541-548. [PMID: 19997980 DOI: 10.1007/s11605-009-1115-0] [Cited by in Crossref: 171] [Cited by in F6Publishing: 150] [Article Influence: 13.2] [Reference Citation Analysis]
2 Halfdanarson TR, Rabe KG, Rubin J, Petersen GM. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008;19:1727-1733. [PMID: 18515795 DOI: 10.1093/annonc/mdn351] [Cited by in Crossref: 473] [Cited by in F6Publishing: 410] [Article Influence: 33.8] [Reference Citation Analysis]
3 Atassi B, Bangash AK, Lewandowski RJ, Ibrahim S, Kulik L, Mulcahy MF, Murthy R, Ryu RK, Sato KT, Miller FH, Omary RA, Salem R. Biliary Sequelae following Radioembolization with Yttrium-90 Microspheres. Journal of Vascular and Interventional Radiology 2008;19:691-7. [DOI: 10.1016/j.jvir.2008.01.003] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 7.1] [Reference Citation Analysis]
4 Vassos N, Agaimy A, Hohenberger W, Croner RS. Management of liver metastases of gastrointestinal stromal tumors (GIST). Annals of Hepatology 2015;14:531-9. [DOI: 10.1016/s1665-2681(19)31175-5] [Cited by in Crossref: 18] [Article Influence: 2.6] [Reference Citation Analysis]
5 Machairas N, Daskalakis K, Felekouras E, Alexandraki KI, Kaltsas G, Sotiropoulos GC. Currently available treatment options for neuroendocrine liver metastases. Ann Gastroenterol 2021;34:130-41. [PMID: 33654350 DOI: 10.20524/aog.2021.0574] [Reference Citation Analysis]
6 Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H, Sugimoto H, Yamada S, Nakao A. Nonfunctioning neuroendocrine pancreatic tumors: our experience and management. J Hepatobiliary Pancreat Surg 2009;16:639-47. [PMID: 19365596 DOI: 10.1007/s00534-009-0099-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
7 Partelli S, Maurizi A, Tamburrino D, Baldoni A, Polenta V, Crippa S, Falconi M. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors. Eur J Endocrinol. 2014;171:R153-R162. [PMID: 24920289 DOI: 10.1530/eje-14-0173] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Xie P, Yuan Z. Acute thrombocytopenia: An uncommon complication occurring following transarterial chemoembolization in a patient with neuroendocrine hepatic metastases. Oncol Lett 2015;10:247-9. [PMID: 26171007 DOI: 10.3892/ol.2015.3232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Gulec SA, Baum R. Radio-guided surgery in neuroendocrine tumors. J Surg Oncol. 2007;96:309-315. [PMID: 17726664 DOI: 10.1002/jso.20868] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
10 Gaba RC, Mendoza-Elias N, Morrison JD, Valeshabad AK, Lipnik AJ. Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors. Semin Intervent Radiol 2017;34:101-8. [PMID: 28579677 DOI: 10.1055/s-0037-1602590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Wei IH, Harmon CM, Arcerito M, Cheng DF, Minter RM, Simeone DM. Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors. Ann Surg 2014;260:1088-94. [PMID: 25389924 DOI: 10.1097/SLA.0000000000000262] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
12 Massani M, Caratozzolo E, Bridda A, Ruffolo C, di Pinto FC, Bonariol L, Rossi S, Bassi N. Isolated thyroidal metastasis as primary manifestation of pancreatic neuroendocrine carcinoma. Pancreas 2010;39:1113-4. [PMID: 20861700 DOI: 10.1097/MPA.0b013e3181db038f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Eto K, Yoshida N, Iwagami S, Iwatsuki M, Baba H. Surgical treatment for gastrointestinal neuroendocrine tumors. Ann Gastroenterol Surg 2020;4:652-9. [PMID: 33319155 DOI: 10.1002/ags3.12396] [Reference Citation Analysis]
14 Vogl TJ, Gruber T, Naguib NN, Hammerstingl R, Nour-Eldin NE. Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols. AJR Am J Roentgenol 2009;193:941-7. [PMID: 19770314 DOI: 10.2214/AJR.08.1879] [Cited by in Crossref: 47] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
15 Howe JR, Cardona K, Fraker DL, Kebebew E, Untch BR, Wang YZ, Law CH, Liu EH, Kim MK, Menda Y, Morse BG, Bergsland EK, Strosberg JR, Nakakura EK, Pommier RF. The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46:715-731. [PMID: 28609357 DOI: 10.1097/mpa.0000000000000846] [Cited by in Crossref: 127] [Cited by in F6Publishing: 57] [Article Influence: 31.8] [Reference Citation Analysis]
16 Pitt SC, Chen H, Kunnimalaiyaan M. Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors. Ann Surg Oncol 2009;16:2936-42. [PMID: 19588205 DOI: 10.1245/s10434-009-0591-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
17 Kühn MW, Blagieva R, Beha D, Hänle M, Reister F, Henne-Bruns D, Pilcher C, Böhm BO, von Wichert G. [A 31-year-old pregnant woman with refractory hypercalcemia]. Internist (Berl) 2012;53:1490-5. [PMID: 23104573 DOI: 10.1007/s00108-012-3149-8] [Reference Citation Analysis]
18 Massironi S, Sciola V, Peracchi M, Ciafardini C, Spampatti MP, Conte D. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol 2008; 14(35): 5377-5384 [PMID: 18803349 DOI: 10.3748/wjg.14.5377] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 78] [Article Influence: 6.7] [Reference Citation Analysis]
19 Sposito C, Droz Dit Busset M, Citterio D, Bongini M, Mazzaferro V. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: Pros and cons. Rev Endocr Metab Disord 2017;18:473-83. [PMID: 29359266 DOI: 10.1007/s11154-017-9439-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
20 Watzka FM, Fottner C, Miederer M, Weber MM, Schad A, Lang H, Musholt TJ. Surgical Treatment of NEN of Small Bowel: A Retrospective Analysis. World J Surg. 2016;40:749-758. [PMID: 26822157 DOI: 10.1007/s00268-016-3432-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
21 Desiato V, Melis M, Amato B, Bianco T, Rocca A, Amato M, Quarto G, Benassai G. Minimally invasive radioguided parathyroid surgery: A literature review. International Journal of Surgery 2016;28:S84-93. [DOI: 10.1016/j.ijsu.2015.12.037] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
22 Kuvshinoff B, Fong Y. Surgical therapy of liver metastases. Semin Oncol 2007;34:177-85. [PMID: 17560979 DOI: 10.1053/j.seminoncol.2007.03.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
23 Frilling A, Weber F, Cicinnati V, Broelsch C. Role of radiolabeled octreotide therapy in patients with metastatic neuroendocrine neoplasms. Expert Rev Endocrinol Metab 2007;2:517-27. [PMID: 30290419 DOI: 10.1586/17446651.2.4.517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Garrot C, Stuart K. Liver-directed therapies for metastatic neuroendocrine tumors. Hematol Oncol Clin North Am 2007;21:545-60; ix-x. [PMID: 17548039 DOI: 10.1016/j.hoc.2007.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
25 Tapia Rico G, Townsend AR, Klevansky M, Price TJ. Liver metastases resection for gastric and esophageal tumors: is there enough evidence to go down this path? Expert Rev Anticancer Ther. 2016;16:1219-1225. [PMID: 27744727 DOI: 10.1080/14737140.2016.1249858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Tsutsumi K, Ohtsuka T, Fujino M, Nakashima H, Aishima S, Ueda J, Takahata S, Nakamura M, Oda Y, Tanaka M. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. J Hepatobiliary Pancreat Sci 2014;21:418-25. [DOI: 10.1002/jhbp.47] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
27 Nadler A, Cukier M, Milot L, Singh S, Law CH. Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach. Can J Surg 2014;57:E2-8. [PMID: 24666455 DOI: 10.1503/cjs.014112] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
28 Grimme FAB, Seesing MFJ, van Hillegersberg R, van Coevorden F, de Jong KP, Nagtegaal ID, Verhoef C, de Wilt JHW; On behalf of the Dutch Liver Surgery Working Group. Liver Resection for Hepatic Metastases from Soft Tissue Sarcoma: A Nationwide Study. Dig Surg. 2019;36:479-486. [PMID: 30253419 DOI: 10.1159/000493389] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
29 Bettini R, Mantovani W, Boninsegna L, Crippa S, Capelli P, Bassi C, Scarpa A, Pederzoli P, Falconi M. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. Dig Liver Dis. 2009;41:49-55. [PMID: 18463008 DOI: 10.1016/j.dld.2008.03.015] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
30 Rajekar H, Bogammana K, Stubbs RS. Selective internal radiation therapy for gastrointestinal neuroendocrine tumour liver metastases: a new and effective modality for treatment. Int J Hepatol 2011;2011:404916. [PMID: 22164335 DOI: 10.4061/2011/404916] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
31 Shao QQ, Zhao BB, Dong LB, Cao HT, Wang WB. Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies. World J Gastroenterol 2019; 25(32): 4673-4681 [PMID: 31528093 DOI: 10.3748/wjg.v25.i32.4673] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Wong KP, Tsang JS, Lang BH. Role of surgery in pancreatic neuroendocrine tumor. Gland Surg 2018;7:36-41. [PMID: 29629318 DOI: 10.21037/gs.2017.12.05] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
33 Saxena A, Chua TC, Perera M, Chu F, Morris DL. Surgical resection of hepatic metastases from neuroendocrine neoplasms: a systematic review. Surg Oncol 2012;21:e131-41. [PMID: 22658833 DOI: 10.1016/j.suronc.2012.05.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
34 Grandhi MS, Lafaro KJ, Pawlik TM. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors. J Gastrointest Surg 2015;19:2273-82. [DOI: 10.1007/s11605-015-2931-z] [Reference Citation Analysis]
35 Gaba RC, Lokken RP, Hickey RM, Lipnik AJ, Lewandowski RJ, Salem R, Brown DB, Walker TG, Silberzweig JE, Baerlocher MO, Echenique AM, Midia M, Mitchell JW, Padia SA, Ganguli S, Ward TJ, Weinstein JL, Nikolic B, Dariushnia SR; Society of Interventional Radiology Standards of Practice Committee. Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy. J Vasc Interv Radiol 2017;28:1210-1223.e3. [PMID: 28669744 DOI: 10.1016/j.jvir.2017.04.025] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
36 Kamat PP, Gupta S, Ensor JE, Murthy R, Ahrar K, Madoff DC, Wallace MJ, Hicks ME. Hepatic Arterial Embolization and Chemoembolization in the Management of Patients with Large-Volume Liver Metastases. Cardiovasc Intervent Radiol 2008;31:299-307. [DOI: 10.1007/s00270-007-9186-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
37 Makary MS, Kapke J, Yildiz V, Pan X, Dowell JD. Conventional versus Drug-Eluting Bead Transarterial Chemoembolization for Neuroendocrine Tumor Liver Metastases. J Vasc Interv Radiol 2016;27:1298-304. [PMID: 27499157 DOI: 10.1016/j.jvir.2016.05.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
38 Katz SC, Donkor C, Glasgow K, Pillarisetty VG, Gönen M, Espat NJ, Klimstra DS, D'Angelica MI, Allen PJ, Jarnagin W, Dematteo RP, Brennan MF, Tang LH. T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases. HPB (Oxford) 2010;12:674-83. [PMID: 21083792 DOI: 10.1111/j.1477-2574.2010.00231.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
39 Le Treut YP, Grégoire E, Belghiti J, Boillot O, Soubrane O, Mantion G, Cherqui D, Castaing D, Ruszniewski P, Wolf P. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant. 2008;8:1205-1213. [PMID: 18444921 DOI: 10.1111/j.1600-6143.2008.02233.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 84] [Article Influence: 8.4] [Reference Citation Analysis]
40 Boleslawski E, Dharancy S, Truant S, Pruvot FR. Surgical management of liver metastases from gastrointestinal endocrine tumors. Gastroenterol Clin Biol 2010;34:274-82. [PMID: 20347242 DOI: 10.1016/j.gcb.2010.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Jensen EH, Kvols L, McLoughlin JM, Lewis JM, Alvarado MD, Yeatman T, Malafa M, Shibata D. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors. Ann Surg Oncol. 2007;14:780-785. [PMID: 17146740 DOI: 10.1245/s10434-006-9148-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
42 Kitano M, Davidson GW, Shirley LA, Schmidt CR, Guy GE, Khabiri H, Dowell JD, Shah MH, Bloomston M. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk? Ann Surg Oncol 2016;23:4008-15. [DOI: 10.1245/s10434-016-5333-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
43 Hibi T, Sano T, Sakamoto Y, Takahashi Y, Uemura N, Ojima H, Shimada K, Kosuge T. Surgery for hepatic neuroendocrine tumors: a single institutional experience in Japan. Jpn J Clin Oncol 2007;37:102-7. [PMID: 17234654 DOI: 10.1093/jjco/hyl140] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
44 Grandhi MS, Lafaro KJ, Pawlik TM. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors. J Gastrointest Surg 2015;19:2273-82. [DOI: 10.1007/s11605-015-2931-z] [Reference Citation Analysis]
45 Nakakura EK, Bergsland EK. Islet Cell Carcinoma: Neuroendocrine Tumors of the Pancreas and Periampullary Region. Hematology/Oncology Clinics of North America 2007;21:457-73. [DOI: 10.1016/j.hoc.2007.04.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
46 Bernheim AM, Connolly HM, Rubin J, Møller JE, Scott CG, Nagorney DM, Pellikka PA. Role of Hepatic Resection for Patients With Carcinoid Heart Disease. Mayo Clinic Proceedings 2008;83:143-50. [DOI: 10.1016/s0025-6196(11)60834-3] [Cited by in Crossref: 31] [Article Influence: 2.2] [Reference Citation Analysis]
47 Bendelow J, Apps E, Jones L, Poston G. Carcinoid syndrome. European Journal of Surgical Oncology (EJSO) 2008;34:289-96. [DOI: 10.1016/j.ejso.2007.07.202] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
48 Cheng SP, Doherty GM. Rare neuroendocrine tumors of the pancreas. Cancer Treat Res 2010;153:253-70. [PMID: 19957229 DOI: 10.1007/978-1-4419-0857-5_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Woltering EA, Voros BA, Beyer DT, Wang YZ, Thiagarajan R, Ryan P, Wright A, Ramirez RA, Ricks MJ, Boudreaux JP. Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution. J Am Coll Surg. 2017;224:434-447. [PMID: 28088602 DOI: 10.1016/j.jamcollsurg.2016.12.032] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
50 Hontani K, Tsuchikawa T, Hiwasa T, Nakamura T, Ueno T, Kushibiki T, Takahashi M, Inoko K, Takano H, Takeuchi S, Dosaka-Akita H, Kuwatani M, Sakamoto N, Hatanaka Y, Mitsuhashi T, Shimada H, Shichinohe T, Hirano S. Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors. Oncotarget 2017;8:106206-21. [PMID: 29290942 DOI: 10.18632/oncotarget.22175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
51 de Mestier L, Zappa M, Hentic O, Vilgrain V, Ruszniewski P. Liver transarterial embolizations in metastatic neuroendocrine tumors. Rev Endocr Metab Disord. 2017;18:459-471. [PMID: 28975561 DOI: 10.1007/s11154-017-9431-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
52 Grandhi MS, Lafaro KJ, Pawlik TM. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors. J Gastrointest Surg 2015;19:2273-82. [DOI: 10.1007/s11605-015-2931-z] [Reference Citation Analysis]
53 Lee SY, Cheow PC, Teo JY, Ooi LL. Surgical treatment of neuroendocrine liver metastases. Int J Hepatol 2012;2012:146590. [PMID: 22319650 DOI: 10.1155/2012/146590] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
54 Fendrich V, Bartsch DK. Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg. 2011;396:299-311. [PMID: 21279821 DOI: 10.1007/s00423-011-0741-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
55 Sugimoto M, Takagi T, Hikichi T, Suzuki R, Watanabe K, Nakamura J, Kikuchi H, Konno N, Waragai Y, Asama H, Takasumi M, Watanabe H, Obara K, Ohira H. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading. World J Gastroenterol 2015; 21(26): 8118-8124 [PMID: 26185384 DOI: 10.3748/wjg.v21.i26.8118] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
56 Luu AM, Herzog T, Uhl W, Braumann C. Liver Metastases 10 Years after Resection of a “Benign” Insulinoma. The American Surgeon 2016;82:326-7. [DOI: 10.1177/000313481608201114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Libicher M, Bovenschulte H. [Arterial embolization of hepatic metastases from neuroendocrine tumors]. Radiologe 2009;49:233-41. [PMID: 19183927 DOI: 10.1007/s00117-008-1787-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Tamburrino D, Spoletini G, Partelli S, Muffatti F, Adamenko O, Crippa S, Falconi M. Surgical management of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab. 2016;30:93-102. [PMID: 26971846 DOI: 10.1016/j.beem.2015.10.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
59 Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor. World J Gastroenterol 2014; 20(39): 14348-14358 [PMID: 25339822 DOI: 10.3748/wjg.v20.i39.14348] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
60 Pinto Marín Á, Hernández Agudo E, Feliú J, González Barón M. Pancreatic glucagonoma presenting as a pulmonary mass. Clin Transl Oncol 2009;11:60-2. [DOI: 10.1007/s12094-009-0312-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
61 Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with multiple liver metastases. World J Hepatol 2014; 6(8): 596-600 [PMID: 25232452 DOI: 10.4254/wjh.v6.i8.596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
62 King J, Quinn R, Glenn DM, Janssen J, Tong D, Liaw W, Morris DL. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer. 2008;113:921-929. [PMID: 18618495 DOI: 10.1002/cncr.23685] [Cited by in Crossref: 196] [Cited by in F6Publishing: 154] [Article Influence: 14.0] [Reference Citation Analysis]
63 Kose E, Kahramangil B, Aydin H, Donmez M, Takahashi H, Aucejo F, Siperstein A, Berber E. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience. Surg Endosc. 2020;34:249-256. [PMID: 30945061 DOI: 10.1007/s00464-019-06759-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
64 Knigge U, Hansen C, Stadil F. Interventional treatment of neuroendocrine liver metastases. The Surgeon 2008;6:232-9. [DOI: 10.1016/s1479-666x(08)80033-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
65 Crosby DA, Donohoe CL, Fitzgerald L, Muldoon C, Hayes B, O'Toole D, Reynolds JV. Gastric neuroendocrine tumours. Dig Surg. 2012;29:331-348. [PMID: 23075625 DOI: 10.1159/000342988] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
66 Chambers AJ, Pasieka JL, Dixon E, Rorstad O. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors. Surgery 2008;144:645-53. [DOI: 10.1016/j.surg.2008.06.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
67 Onesti JK, Shirley LA, Saunders ND, Davidson GW, Dillhoff ME, Khabiri H, Guy GE, Dowell JD, Schmidt CR, Shah MH, Bloomston M. Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes. J Gastrointest Surg 2016;20:580-6. [PMID: 26489743 DOI: 10.1007/s11605-015-2998-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
68 Hill JS, McPhee JT, McDade TP, Zhou Z, Sullivan ME, Whalen GF, Tseng JF. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer. 2009;115:741-751. [PMID: 19130464 DOI: 10.1002/cncr.24065] [Cited by in Crossref: 201] [Cited by in F6Publishing: 187] [Article Influence: 15.5] [Reference Citation Analysis]
69 Concors SJ, Sinnamon AJ, Ecker BL, Metz DC, Vollmer CM, Fraker DL, Roses RE. The impact of surgery for metastatic pancreatic neuroendocrine tumor: a contemporary evaluation matching for chromogranin a level. HPB (Oxford) 2020;22:83-90. [PMID: 31239188 DOI: 10.1016/j.hpb.2019.05.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Krausch M, Raffel A, Anlauf M, Schott M, Lehwald N, Krieg A, Topp SA, Cupisti K, Knoefel WT. “Cherry Picking”, a Multiple Non-anatomic Liver Resection Technique, as a Promising Option for Diffuse Liver Metastases in Patients with Neuroendocrine Tumours. World J Surg 2014;38:392-401. [DOI: 10.1007/s00268-013-2267-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
71 Gulec SA. PET probe-guided surgery. J Surg Oncol 2007;96:353-7. [PMID: 17726667 DOI: 10.1002/jso.20862] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
72 Lee HW, Chung JW, Kim YJ, Kwon KA, Kim EJ, Kim KK, Lee WK, Sym SJ. Synchronous Peripancreatic Lymph Node Gastrinoma and Gastric Neuroendocrine Tumor Type 2. Clin Endosc 2016;49:483-7. [PMID: 27209642 DOI: 10.5946/ce.2016.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Norlén O, Stålberg P, Öberg K, Eriksson J, Hedberg J, Hessman O, Janson ET, Hellman P, Åkerström G. Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center. World J Surg 2012;36:1419-31. [DOI: 10.1007/s00268-011-1296-z] [Cited by in Crossref: 133] [Cited by in F6Publishing: 115] [Article Influence: 12.1] [Reference Citation Analysis]
74 Singla S, LeVea CM, Pokuri VK, Attwood KM, Wach MM, Tomaszewski GM, Kuvshinoff B, Iyer R. Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience. J Gastrointest Oncol 2016;7:441-8. [PMID: 27284478 DOI: 10.21037/jgo.2016.02.02] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
75 Yang TX, Chua TC, Morris DL. Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review. Surg Oncol 2012;21:299-308. [PMID: 22846894 DOI: 10.1016/j.suronc.2012.07.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
76 Chan MY, Ma KW, Chan A. Surgical management of neuroendocrine tumor-associated liver metastases: a review. Gland Surg 2018;7:28-35. [PMID: 29629317 DOI: 10.21037/gs.2017.11.16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
77 Partelli S, Maurizi A, Tamburrino D, Crippa S, Pandolfi S, Falconi M. Surgical management of pancreatic neuroendocrine neoplasms. Ann Saudi Med 2014;34:1-5. [PMID: 24658547 DOI: 10.5144/0256-4947.2014.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
78 Birnbaum DJ, Turrini O, Ewald J, Barbier L, Autret A, Hardwigsen J, Brunet C, Moutardier V, Le Treut YP, Delpero JR. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival. Eur J Surg Oncol. 2014;40:1564-1571. [PMID: 25086992 DOI: 10.1016/j.ejso.2014.06.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
79 Chung H, Chapman WC. Liver transplantation for metastatic neuroendocrine tumors. Adv Surg. 2014;48:235-252. [PMID: 25293619 DOI: 10.1016/j.yasu.2014.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
80 Hodul PJ, Strosberg JR, Kvols LK. Aggressive Surgical Resection in the Management of Pancreatic Neuroendocrine Tumors: When is it Indicated? Cancer Control 2008;15:314-21. [DOI: 10.1177/107327480801500406] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
81 Yeung MJ, Pasieka JL. Gastrinomas: A historical perspective: Gastrinomas. J Surg Oncol 2009;100:425-33. [DOI: 10.1002/jso.21359] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
82 Cho CS, Labow DM, Tang L, Klimstra DS, Loeffler AG, Leverson GE, Fong Y, Jarnagin WR, D’Angelica MI, Weber SM. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms. Cancer. 2008;113:126-134. [PMID: 18457323 DOI: 10.1002/cncr.23523] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
83 Goldstein R, Meyer T. Role of everolimus in pancreatic neuroendocrine tumors. Expert Rev Anticancer Ther. 2011;11:1653-1665. [PMID: 21932937 DOI: 10.1586/era.11.145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
84 Harring TR, Nguyen NT, Goss JA, O’Mahony CA. Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review. Int J Hepatol. 2011;2011:154541. [PMID: 22013537 DOI: 10.4061/2011/154541] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
85 Saraf K, Tingi E, Brodison A, Sinha S. A rare case of primary ovarian carcinoid. Gynecol Endocrinol 2017;33:766-9. [PMID: 28531365 DOI: 10.1080/09513590.2017.1328049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Chan JA, Kulke MH. New treatment options for patients with advanced neuroendocrine tumors. Curr Treat Options Oncol 2011;12:136-48. [PMID: 21437592 DOI: 10.1007/s11864-011-0148-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
87 Hoffmann RT, Paprottka P, Jakobs TF, Trumm CG, Reiser MF. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Abdom Imaging 2011;36:671-6. [DOI: 10.1007/s00261-011-9753-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
88 Lowery AJ, Walsh S, McDermott EW, Prichard RS. Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas. Oncologist. 2013;18:391-407. [PMID: 23576482 DOI: 10.1634/theoncologist.2012-0410] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
89 Ruzzenente A, Bagante F, Bertuzzo F, Aldrighetti L, Ercolani G, Giuliante F, Ferrero A, Torzilli G, Grazi GL, Ratti F, Cucchetti A, De Rose AM, Russolillo N, Cimino M, Perri P, Cataldo I, Scarpa A, Guglielmi A, Iacono C. A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database. J Gastrointest Surg 2017;21:41-8. [DOI: 10.1007/s11605-016-3228-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
90 Bösch F, Hofmann K, Coenen M, Pratschke S, Thomas M, Knösel T, Bruns CJ, Guba M, Werner J, Angele MK. Surgical treatment of pNET - Experience of a "high-volume" center. Surg Oncol 2018;27:409-14. [PMID: 30217295 DOI: 10.1016/j.suronc.2018.05.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
91 Bruzoni M, Parikh P, Celis R, Are C, Ly QP, Meza JL, Sasson AR. Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review. Am J Surg. 2009;197:376-381. [PMID: 19245918 DOI: 10.1016/j.amjsurg.2008.11.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
92 Grandhi MS, Lafaro KJ, Pawlik TM. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors. J Gastrointest Surg. 2015;19:2273-2282. [PMID: 26341823 DOI: 10.1007/s11605-015-2931-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
93 Marudanayagam R, Sandhu B, Perera MT, Taniere P, Coldham C, Bramhall S, Mayer D, Buckels J, Mirza D. Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma metastasis: a single-centre experience. HPB (Oxford) 2011;13:286-92. [PMID: 21418135 DOI: 10.1111/j.1477-2574.2010.00285.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
94 Fairweather M, Swanson R, Wang J, Brais LK, Dutton T, Kulke MH, Clancy TE. Management of Neuroendocrine Tumor Liver Metastases: Long-Term Outcomes and Prognostic Factors from a Large Prospective Database. Ann Surg Oncol. 2017;24:2319-2325. [PMID: 28303430 DOI: 10.1245/s10434-017-5839-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 9.8] [Reference Citation Analysis]
95 Reidy-Lagunes D, Thornton R. Pancreatic neuroendocrine and carcinoid tumors: what’s new, what’s old, and what’s different? Curr Oncol Rep. 2012;14:249-256. [PMID: 22434313 DOI: 10.1007/s11912-012-0232-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
96 Boninsegna L, Panzuto F, Partelli S, Capelli P, Delle Fave G, Bettini R, Pederzoli P, Scarpa A, Falconi M. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections. Eur J Cancer. 2012;48:1608-1615. [PMID: 22129889 DOI: 10.1016/j.ejca.2011.10.030] [Cited by in Crossref: 103] [Cited by in F6Publishing: 96] [Article Influence: 9.4] [Reference Citation Analysis]
97 Chambers AJ, Pasieka JL, Dixon E, Rorstad O. Role of Imaging in the Preoperative Staging of Small Bowel Neuroendocrine Tumors. Journal of the American College of Surgeons 2010;211:620-7. [DOI: 10.1016/j.jamcollsurg.2010.07.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
98 Povoski SP, Neff RL, Mojzisik CM, O'Malley DM, Hinkle GH, Hall NC, Murrey DA Jr, Knopp MV, Martin EW Jr. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol 2009;7:11. [PMID: 19173715 DOI: 10.1186/1477-7819-7-11] [Cited by in Crossref: 151] [Cited by in F6Publishing: 98] [Article Influence: 11.6] [Reference Citation Analysis]
99 Zhang MY, He D, Zhang S. Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment. World J Gastrointest Oncol 2020; 12(7): 705-718 [PMID: 32864039 DOI: 10.4251/wjgo.v12.i7.705] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Yamamoto M, Yoshida M, Furuse J, Sano K, Ohtsuka M, Yamashita S, Beppu T, Iwashita Y, Wada K, Nakajima TE, Sakamoto K, Hayano K, Mori Y, Asai K, Matsuyama R, Hirashita T, Hibi T, Sakai N, Tabata T, Kawakami H, Takeda H, Mizukami T, Ozaka M, Ueno M, Naito Y, Okano N, Ueno T, Hijioka S, Shikata S, Ukai T, Strasberg S, Sarr MG, Jagannath P, Hwang TL, Han HS, Yoon YS, Wang HJ, Luo SC, Adam R, Gimenez M, Scatton O, Oh DY, Takada T. Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021. J Hepatobiliary Pancreat Sci 2021;28:1-25. [PMID: 33200538 DOI: 10.1002/jhbp.868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
101 Hu H, Zhao H. Report of one case: surgical treatment for neuroendocrine tumors. Transl Gastroenterol Hepatol 2016;1:83. [PMID: 28138648 DOI: 10.21037/tgh.2016.10.05] [Reference Citation Analysis]
102 Fernández-cruz L, Romero J, Zelaya R, Olvera C, Maglio L. Surgical strategies for nonfunctioning neuroendocrine pancreatic tumors and for other pancreatic neoplasms associated with multiple endocrine neoplasia type 1. The American Journal of Surgery 2007;194:S143-7. [DOI: 10.1016/j.amjsurg.2007.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Zhao YP, Zhan HX, Zhang TP, Cong L, Dai MH, Liao Q, Cai LX. Surgical management of patients with insulinomas: Result of 292 cases in a single institution. J Surg Oncol. 2011;103:169-174. [PMID: 21259252 DOI: 10.1002/jso.21773] [Cited by in Crossref: 83] [Cited by in F6Publishing: 61] [Article Influence: 6.9] [Reference Citation Analysis]
104 Jensen RT, Norton JA. Endocrine Tumors of the Pancreas and Gastrointestinal Tract. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 491-522.e7. [DOI: 10.1016/b978-1-4160-6189-2.00032-9] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
105 Pitt SC, Knuth J, Keily JM, McDermott JC, Weber SM, Chen H, Rilling WS, Quebbeman EJ, Agarwal DM, Pitt HA. Hepatic neuroendocrine metastases: chemo- or bland embolization? J Gastrointest Surg. 2008;12:1951-1960. [PMID: 18709512 DOI: 10.1007/s11605-008-0640-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 5.4] [Reference Citation Analysis]
106 Basuroy R, Srirajaskanthan R, Ramage JK. A multimodal approach to the management of neuroendocrine tumour liver metastases. Int J Hepatol 2012;2012:819193. [PMID: 22518323 DOI: 10.1155/2012/819193] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
107 Sakuma Y, Yasuda Y, Sata N, Hosoya Y, Shimizu A, Fujii H, Matsubara D, Fukushima N, Miki A, Maeno M, Lefor AK. Pancreatic neuroendocrine tumor with metastasis to the spleen: a case report. BMC Cancer 2017;17:37. [PMID: 28068959 DOI: 10.1186/s12885-016-3020-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Akyildiz HY, Mitchell J, Milas M, Siperstein A, Berber E. Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: long-term follow-up. Surgery 2010;148:1288-93; discussion 1293. [PMID: 21134563 DOI: 10.1016/j.surg.2010.09.014] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 8.8] [Reference Citation Analysis]
109 Kawasaki K, Kawaguchi Y, Suzuki Y, Tanaka N. Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase. BMJ Case Rep 2016;2016:bcr2016214759. [PMID: 27803081 DOI: 10.1136/bcr-2016-214759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
110 Grandhi MS, Lafaro KJ, Pawlik TM. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors. J Gastrointest Surg 2015;19:2273-82. [DOI: 10.1007/s11605-015-2931-z] [Reference Citation Analysis]
111 Baechle JJ, Marincola Smith P, Tan M, Solórzano CC, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides G, Makris E, Rocha FG, Crown A, Cho C, Beems M, Winslow ER, Rendell VR, Krasnick BA, Fields R, Maithel SK, Bailey CE, Idrees K. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group. Ann Surg Oncol 2020;27:3915-23. [PMID: 32328982 DOI: 10.1245/s10434-020-08497-4] [Reference Citation Analysis]
112 Mazzaglia PJ, Berber E, Milas M, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery. 2007;142:10-19. [PMID: 17629995 DOI: 10.1016/j.surg.2007.01.036] [Cited by in Crossref: 178] [Cited by in F6Publishing: 150] [Article Influence: 11.9] [Reference Citation Analysis]
113 Del Prete M, Fiore F, Modica R, Marotta V, Marciello F, Ramundo V, Di Sarno A, Carratù A, di Roseto Cde L, Tafuto S, Tatangelo F, Baldelli R, Colao A, Faggiano A; Multidisciplinary Group for NeuroEndocrine Tumors of Naples. Hepatic arterial embolization in patients with neuroendocrine tumors. J Exp Clin Cancer Res 2014;33:43. [PMID: 24887262 DOI: 10.1186/1756-9966-33-43] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
114 Mazzaglia PJ, Berber E, Siperstein AE. Radiofrequency Thermal Ablation of Metastatic Neuroendocrine Tumors in the Liver. Curr Treat Options in Oncol 2007;8:322-30. [DOI: 10.1007/s11864-007-0038-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
115 Maschuw K, Fendrich V, Langer P, Volland C, Ramaswamy A, Bartsch DK. Impact of CT-based diagnostic imaging on management and outcome of nonfunctioning pancreatic tumors. Langenbecks Arch Surg 2011;396:1181-6. [PMID: 21318575 DOI: 10.1007/s00423-011-0748-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
116 Valadares LJ, Costa Junior W, Ribeiro HS, Diniz AL, Coimbra FJ, Herman P. Resection of liver metastasis from neuroendocrine tumors: evaluation of results and prognostic factors. Rev Col Bras Cir. 2015;42:25-31. [PMID: 25992697 DOI: 10.1590/0100-69912015001006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
117 Charalampoudis P, Mantas D, Sotiropoulos GC, Dimitroulis D, Kouraklis G, Markopoulos C. Surgery for liver metastases from breast cancer. Future Oncol. 2015;11:1519-1530. [PMID: 25963429 DOI: 10.2217/fon.15.43] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
118 Jiménez-fonseca P, Carmona-bayonas A, Martín-pérez E, Crespo G, Serrano R, Llanos M, Villabona C, García-carbonero R, Aller J, Capdevila J, Grande E; On behalf of the Spanish Neuroendocrine Tumor Group (GETNE). Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors. Cancer Metastasis Rev 2015;34:381-400. [DOI: 10.1007/s10555-015-9573-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
119 Gutierrez G, Daniels IR, Garcia A, Ramia JM. Peritoneal carcinomatosis from a small bowel carcinoid tumour. World J Surg Oncol 2006;4:75. [PMID: 17083717 DOI: 10.1186/1477-7819-4-75] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
120 Lee E, Leon Pachter H, Sarpel U. Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors. Int J Hepatol. 2012;2012:471203. [PMID: 22319651 DOI: 10.1155/2012/471203] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
121 Gregoire E, Le Treut YP. Liver transplantation for primary or secondary endocrine tumors. Transpl Int. 2010;23:704-711. [PMID: 20492617 DOI: 10.1111/j.1432-2277.2010.01110.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
122 Gomez-Rivera F, Stewart AE, Arnoletti JP, Vickers S, Bland KI, Heslin MJ. Surgical treatment of pancreatic endocrine neoplasms. Am J Surg. 2007;193:460-465. [PMID: 17368289 DOI: 10.1016/j.amjsurg.2006.10.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
123 Frilling A, Li J, Malamutmann E, Schmid KW, Bockisch A, Broelsch CE. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg 2009;96:175-84. [PMID: 19160361 DOI: 10.1002/bjs.6468] [Cited by in Crossref: 141] [Cited by in F6Publishing: 110] [Article Influence: 10.8] [Reference Citation Analysis]
124 Foubert F, Salimon M, Dumars C, Regenet N, Girot P, Venara A, Senellart H, Heymann MF, Matysiak-Budnik T, Touchefeu Y. Survival and prognostic factors analysis of 151 intestinal and pancreatic neuroendocrine tumors: a single center experience. J Gastrointest Oncol 2019;10:103-11. [PMID: 30788165 DOI: 10.21037/jgo.2018.09.13] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Gulec SA, Hoenie E, Hostetter R, Schwartzentruber D. PET probe-guided surgery: applications and clinical protocol. World J Surg Oncol 2007;5:65. [PMID: 17555587 DOI: 10.1186/1477-7819-5-65] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
126 Bilimoria KY, Tomlinson JS, Merkow RP, Stewart AK, Ko CY, Talamonti MS, Bentrem DJ. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients. J Gastrointest Surg. 2007;11:1460-1467; discussion 1467-1469. [PMID: 17846854 DOI: 10.1007/s11605-007-0263-3] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 7.4] [Reference Citation Analysis]
127 Zlate AC, Alexandrescu ST, Grigorie RT, Gramaticu IM, Kraft A, Dumitru R, Tomescu D, Popescu I. THE ROLE OF SURGERY IN A PATIENT WITH CARCINOID SYNDROME, COMPLICATED BY CARCINOID HEART DISEASE. Acta Endocrinol (Buchar) 2018;14:117-21. [PMID: 31149245 DOI: 10.4183/aeb.2018.117] [Reference Citation Analysis]
128 Pitt SC, Pitt HA, Baker MS, Christians K, Touzios JG, Kiely JM, Weber SM, Wilson SD, Howard TJ, Talamonti MS. Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg. 2009;13:1692-1698. [PMID: 19548038 DOI: 10.1007/s11605-009-0946-z] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
129 Fendrich V, Michl P, Habbe N, Bartsch DK. Liver-specific therapies for metastases of neuroendocrine pancreatic tumors. World J Hepatol 2010; 2(10): 367-373 [PMID: 21160945 DOI: 10.4254/wjh.v2.i10.367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
130 Cheung TT, Chok KS, Chan AC, Tsang S, Dai JW, Lang BH, Yau T, Chan SC, Poon RT, Fan ST, Lo CM. Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases. ScientificWorldJournal 2014;2014:524045. [PMID: 24526905 DOI: 10.1155/2014/524045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
131 D’Haese JG, Tosolini C, Ceyhan GO, Kong B, Esposito I, Michalski CW, Kleeff J. Update on surgical treatment of pancreatic neuroendocrine neoplasms. World J Gastroenterol 2014; 20(38): 13893-13898 [PMID: 25320524 DOI: 10.3748/wjg.v20.i38.13893] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
132 Konishi T, Watanabe T, Kishimoto J, Kotake K, Muto T, Nagawa H; Japanese Society for Cancer of the Colon and Rectum. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007;56:863-868. [PMID: 17213340 DOI: 10.1136/gut.2006.109157] [Cited by in Crossref: 149] [Cited by in F6Publishing: 124] [Article Influence: 9.9] [Reference Citation Analysis]
133 Bhagat N, Reyes DK, Lin M, Kamel I, Pawlik TM, Frangakis C, Geschwind JF. Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury. Cardiovasc Intervent Radiol 2013;36:449-59. [PMID: 22722717 DOI: 10.1007/s00270-012-0424-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
134 Schmelzle M, Eisenberger CF, am Esch JS 2nd, Matthaei H, Krausch M, Knoefel WT. Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: resection as a promising tool in the palliative management. Langenbecks Arch Surg 2010;395:227-34. [PMID: 19998042 DOI: 10.1007/s00423-009-0580-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
135 Su H, Zhou H. Rectal neuroendocrine neoplasms: a case report. Transl Gastroenterol Hepatol 2016;1:49. [PMID: 28138616 DOI: 10.21037/tgh.2016.05.09] [Reference Citation Analysis]
136 Alekberzade AV, Krylov NN, Lipnitskiy EM, Shakhbazov RO, Azari F. [Gastric neuroendocrine tumors]. Khirurgiia (Mosk) 2019;:111-20. [PMID: 31825351 DOI: 10.17116/hirurgia2019121111] [Reference Citation Analysis]
137 Muniraj T, Vignesh S, Shetty S, Thiruvengadam S, Aslanian HR. Pancreatic neuroendocrine tumors. Disease-a-Month 2013;59:5-19. [DOI: 10.1016/j.disamonth.2012.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
138 Maithel SK, Fong Y. Hepatic ablation for neuroendocrine tumor metastases. J Surg Oncol. 2009;100:635-638. [PMID: 20017158 DOI: 10.1002/jso.21196] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
139 Tran CG, Sherman SK, Chandrasekharan C, Howe JR. Surgical Management of Neuroendocrine Tumor Liver Metastases. Surg Oncol Clin N Am 2021;30:39-55. [PMID: 33220808 DOI: 10.1016/j.soc.2020.08.001] [Reference Citation Analysis]
140 Vyleta M, Coldwell D. Radioembolization in the treatment of neuroendocrine tumor metastases to the liver. Int J Hepatol 2011;2011:785315. [PMID: 22235376 DOI: 10.4061/2011/785315] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
141 Fendrich V, Langer P, Waldmann J, Bartsch DK, Rothmund M. Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas. Br J Surg. 2007;94:1331-1341. [PMID: 17939142 DOI: 10.1002/bjs.5987] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
142 Manguso N, Nissen N, Hendifar A, Harit A, Mirocha J, Friedman M, Lipshutz HG, Amersi F. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases. J Surg Oncol 2019;120:926-31. [PMID: 31396982 DOI: 10.1002/jso.25657] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
143 Yu X, Gu J, Wu H, Fu D, Li J, Jin C. Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. J Oncol. 2018;2018:6273947. [PMID: 30538745 DOI: 10.1155/2018/6273947] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
144 Page AJ, Weiss MJ, Pawlik TM. Surgical management of noncolorectal cancer liver metastases: Noncolorectal Liver Metatases. Cancer 2014;120:3111-21. [DOI: 10.1002/cncr.28743] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
145 Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA, Kulik L, Geschwind JF, Murthy R, Rilling W, Liu D, Bester L, Bilbao JI, Kennedy AS, Omary RA, Salem R. Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30:571-592. [PMID: 17516113 DOI: 10.1007/s00270-007-9064-z] [Cited by in Crossref: 198] [Cited by in F6Publishing: 177] [Article Influence: 13.2] [Reference Citation Analysis]
146 Hanazaki K, Sakurai A, Munekage M, Ichikawa K, Namikawa T, Okabayashi T, Imamura M. Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1. Surg Today. 2013;43:229-236. [PMID: 23076685 DOI: 10.1007/s00595-012-0376-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
147 Bhutiani N, Bruenderman EH, Jones JM, Wehry JH, Egger ME, Philips P, Scoggins CR, McMasters KM, Martin RCG. A literature-based treatment algorithm for low-grade neuroendocrine liver metastases. HPB (Oxford) 2021;23:63-70. [PMID: 32448647 DOI: 10.1016/j.hpb.2020.04.012] [Reference Citation Analysis]
148 Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol 2018;25:1709-15. [PMID: 29626307 DOI: 10.1245/s10434-018-6468-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
149 Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, Celinksi SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Ferrero A, Schulick RD, Choti MA, Mentha G, Strub J, Bauer TW, Adams RB, Aldrighetti L, Capussotti L, Pawlik TM. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010;17:3129-3136. [PMID: 20585879 DOI: 10.1245/s10434-010-1154-5] [Cited by in Crossref: 266] [Cited by in F6Publishing: 218] [Article Influence: 22.2] [Reference Citation Analysis]
150 Schmidt C, Bloomston M, Shah MH. Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies. Oncogene 2011;30:1497-505. [PMID: 21132004 DOI: 10.1038/onc.2010.548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
151 Hansen PD, Cassera MA, Wolf RF. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver. Surg Oncol Clin N Am 2015;24:97-119. [PMID: 25444471 DOI: 10.1016/j.soc.2014.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
152 Lim E, Goldstraw P, Nicholson AG, Travis WD, Jett JR, Ferolla P, Bomanji J, Rusch VW, Asamura H, Skogseid B, Baudin E, Caplin M, Kwekkeboom D, Brambilla E, Crowley J. Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007. J Thorac Oncol 2008;3:1194-201. [PMID: 18827620 DOI: 10.1097/JTO.0b013e3181861d7b] [Cited by in Crossref: 59] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
153 Singh S, Asa SL, Dey C, Kennecke H, Laidley D, Law C, Asmis T, Chan D, Ezzat S, Goodwin R. Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus. Cancer Treat Rev. 2016;47:32-45. [PMID: 27236421 DOI: 10.1016/j.ctrv.2016.05.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
154 Frilling A, Clift AK. Therapeutic strategies for neuroendocrine liver metastases. Cancer 2015;121:1172-86. [PMID: 25274401 DOI: 10.1002/cncr.28760] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 10.4] [Reference Citation Analysis]
155 Gunvén P. Liver embolizations in oncology: A review: Part I. Arterial (chemo)embolizations. Med Oncol 2008;25:1-11. [DOI: 10.1007/s12032-007-0039-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
156 Salem R, Thurston KG. Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies. Journal of Vascular and Interventional Radiology 2006;17:1425-39. [DOI: 10.1097/01.rvi.0000235779.88652.53] [Cited by in Crossref: 151] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
157 Nguyen NT, Harring TR, Goss JA, O'Mahony CA. Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience. Int J Hepatol. 2011;2011:742890. [PMID: 22254141 DOI: 10.4061/2011/742890] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
158 Falconi M, Plockinger U, Kwekkeboom DJ, Manfredi R, Korner M, Kvols L, Pape UF, Ricke J, Goretzki PE, Wildi S. Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology. 2006;84:196-211. [PMID: 17312380 DOI: 10.1159/000098012] [Cited by in Crossref: 179] [Cited by in F6Publishing: 142] [Article Influence: 11.9] [Reference Citation Analysis]
159 Lo SS, Moffatt-bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman RD. The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 2011;8:405-16. [DOI: 10.1038/nrclinonc.2011.75] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
160 Kasuga A, Chino A, Uragami N, Kishihara T, Igarashi M, Fujita R, Yamamoto N, Ueno M, Oya M, Muto T. Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution. J Gastroenterol Hepatol. 2012;27:1801-1807. [PMID: 22743039 DOI: 10.1111/j.1440-1746.2012.07218.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
161 Fendrich V, Langer P, Celik I, Bartsch DK, Zielke A, Ramaswamy A, Rothmund M. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg. 2006;244:845-851; discussion 852-853. [PMID: 17122609 DOI: 10.1097/01.sla.0000246951.21252.60] [Cited by in Crossref: 114] [Cited by in F6Publishing: 92] [Article Influence: 7.6] [Reference Citation Analysis]
162 Åkerström G, Norlén O, Edfeldt K, Crona J, Björklund P, Westin G, Hellman P, Stålberg P. A review on management discussions of small intestinal neuroendocrine tumors ‘midgut carcinoids’. International Journal of Endocrine Oncology 2015;2:119-28. [DOI: 10.2217/ije.15.2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
163 Tsutsumi K, Ohtsuka T, Mori Y, Fujino M, Yasui T, Aishima S, Takahata S, Nakamura M, Ito T, Tanaka M. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production. J Gastroenterol. 2012;47:678-685. [PMID: 22350698 DOI: 10.1007/s00535-012-0540-0] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
164 Shrikhande SV, Sirohi B, Goel M, Barreto SG. Pancreatic neuroendocrine tumors. Indian J Gastroenterol 2013;32:3-17. [PMID: 23054950 DOI: 10.1007/s12664-012-0257-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
165 Arciero CA, Sigurdson ER. Diagnosis and treatment of metastatic disease to the liver. Semin Oncol 2008;35:147-59. [PMID: 18396200 DOI: 10.1053/j.seminoncol.2007.12.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
166 Chambers AJ, Pasieka JL. Gastrinoma. Cancer Treat Res 2010;153:213-33. [PMID: 19957227 DOI: 10.1007/978-1-4419-0857-5_12] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
167 Sher LS, Levi DM, Wecsler JS, Lo M, Petrovic LM, Groshen S, Ji L, Uso TD, Tector AJ, Hamilton AS, Marsh JW, Schwartz ME. Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables. J Surg Oncol 2015;112:125-32. [PMID: 26171686 DOI: 10.1002/jso.23973] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
168 Virmani S, Ryu RK, Sato KT, Lewandowski RJ, Kulik L, Mulcahy MF, Larson AC, Salem R, Omary RA. Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. J Vasc Interv Radiol. 2007;18:1305-1309. [PMID: 17911523 DOI: 10.1016/j.jvir.2007.07.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
169 Frilling A, Sotiropoulos GC, Li J, Kornasiewicz O, Plöckinger U. Multimodal management of neuroendocrine liver metastases. HPB (Oxford). 2010;12:361-379. [PMID: 20662787 DOI: 10.1111/j.1477-2574.2010.00175.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 8.5] [Reference Citation Analysis]
170 Fernández-Cruz L, Blanco L, Cosa R, Rendón H. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg. 2008;32:904-917. [PMID: 18264824 DOI: 10.1007/s00268-008-9467-2] [Cited by in Crossref: 141] [Cited by in F6Publishing: 113] [Article Influence: 10.1] [Reference Citation Analysis]
171 Sham JG, Ejaz A, Gage MM, Bagante F, Reames BN, Maithel S, Poultsides GA, Bauer TW, Fields RC, Weiss MJ, Marques HP, Aldrighetti L, Pawlik TM, He J. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study. J Gastrointest Surg. 2019;23:484-491. [PMID: 29980977 DOI: 10.1007/s11605-018-3862-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
172 Davi MV, Pia A, Guarnotta V, Pizza G, Colao A, Faggiano A; NIKE Group. The treatment of hyperinsulinemic hypoglycaemia in adults: an update. J Endocrinol Invest 2017;40:9-20. [PMID: 27624297 DOI: 10.1007/s40618-016-0536-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
173 Ohmoto A, Rokutan H, Yachida S. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future. Int J Mol Sci 2017;18:E143. [PMID: 28098761 DOI: 10.3390/ijms18010143] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
174 Vogl TJ, Naguib NN, Zangos S, Eichler K, Hedayati A, Nour-Eldin NE. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur J Radiol. 2009;72:517-528. [PMID: 18829195 DOI: 10.1016/j.ejrad.2008.08.008] [Cited by in Crossref: 109] [Cited by in F6Publishing: 93] [Article Influence: 7.8] [Reference Citation Analysis]
175 Steward MJ, Warbey VS, Malhotra A, Caplin ME, Buscombe JR, Yu D. Neuroendocrine tumors: role of interventional radiology in therapy. Radiographics 2008;28:1131-45. [PMID: 18635633 DOI: 10.1148/rg.284075170] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
176 Akerström G, Hellman P. Surgical aspects of neuroendocrine tumours. Eur J Cancer 2009;45 Suppl 1:237-50. [PMID: 19775622 DOI: 10.1016/S0959-8049(09)70039-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
177 Barreto SG, Shukla PJ, Shrikhande SV. Tumors of the Pancreatic Body and Tail. World J Oncol. 2010;1:52-65. [PMID: 29147182 DOI: 10.4021/wjon2010.04.200w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
178 Tran CG, Sherman SK, Howe JR. The Landmark Series: Management of Small Bowel Neuroendocrine Tumors. Ann Surg Oncol 2021;28:2741-51. [PMID: 33452604 DOI: 10.1245/s10434-020-09566-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Prieto-Montaño J, Salazar W, Reyna-Villasmil E, de Nobrega-Correa H. [Small cell neuroendocrine carcinoma of the colon]. Gastroenterol Hepatol 2011;34:54-6. [PMID: 21216046 DOI: 10.1016/j.gastrohep.2010.09.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Lal A, Chen H. Treatment of advanced carcinoid tumors. Curr Opin Oncol 2006;18:9-15. [PMID: 16357558 DOI: 10.1097/01.cco.0000198018.53606.62] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
181 Kuo JH, Lee JA, Chabot JA. Nonfunctional pancreatic neuroendocrine tumors. Surg Clin North Am. 2014;94:689-708. [PMID: 24857584 DOI: 10.1016/j.suc.2014.02.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
182 Folkert IW, Hernandez P, Roses RE. Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas. World J Gastroenterol 2016; 22(11): 3105-3116 [PMID: 27003988 DOI: 10.3748/wjg.v22.i11.3105] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
183 Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'connor JM, Salazar R, Taal BG, Vullierme MP, O'toole D. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors. Neuroendocrinology 2012;95:120-34. [DOI: 10.1159/000335587] [Cited by in Crossref: 326] [Cited by in F6Publishing: 261] [Article Influence: 32.6] [Reference Citation Analysis]
184 Kianmanesh R, Sauvanet A, Hentic O, Couvelard A, Lévy P, Vilgrain V, Ruszniewski P, Belghiti J. Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection. Ann Surg. 2008;247:659-665. [PMID: 18362629 DOI: 10.1097/sla.0b013e31816a7061] [Cited by in Crossref: 82] [Cited by in F6Publishing: 24] [Article Influence: 5.9] [Reference Citation Analysis]
185 Vilchez V, Gedaly R. Liver transplantation for the treatment of neuroendocrine liver metastases. Best Practice & Research Clinical Endocrinology & Metabolism 2016;30:141-7. [DOI: 10.1016/j.beem.2016.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
186 Mayo SC, de Jong MC, Bloomston M, Pulitano C, Clary BM, Reddy SK, Clark Gamblin T, Celinski SA, Kooby DA, Staley CA, Stokes JB, Chu CK, Arrese D, Ferrero A, Schulick RD, Choti MA, Geschwind JF, Strub J, Bauer TW, Adams RB, Aldrighetti L, Mentha G, Capussotti L, Pawlik TM. Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol 2011;18:3657-65. [PMID: 21681380 DOI: 10.1245/s10434-011-1832-y] [Cited by in Crossref: 113] [Cited by in F6Publishing: 98] [Article Influence: 10.3] [Reference Citation Analysis]
187 Mittendorf EA, Shifrin AL, Inabnet WB, Libutti SK, Mchenry CR, Demeure MJ. Islet Cell Tumors. Current Problems in Surgery 2006;43:685-765. [DOI: 10.1067/j.cpsurg.2006.07.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
188 Busquets J, Ramírez-Maldonado E, Serrano T, Peláez N, Secanella L, Ruiz-Osuna S, Ramos E, Lladó L, Fabregat J. Surgical treatment of non-functioning pancreatic neuroendocrine tumours based on three clinical scenarios. Cir Esp 2016;94:578-87. [PMID: 27863693 DOI: 10.1016/j.ciresp.2016.07.008] [Reference Citation Analysis]
189 Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, Chen H, Jensen RT, Kim MK, Klimstra DS, Kulke MH, Liu EH, Metz DC, Phan AT, Sippel RS, Strosberg JR, Yao JC; North American Neuroendocrine Tumor Society. Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas. 2013;42:557-577. [PMID: 23591432 DOI: 10.1097/mpa.0b013e31828e34a4] [Cited by in Crossref: 326] [Cited by in F6Publishing: 141] [Article Influence: 36.2] [Reference Citation Analysis]
190 Frilling A, Akerström G, Falconi M, Pavel M, Ramos J, Kidd M, Modlin IM. Neuroendocrine tumor disease: an evolving landscape. Endocr Relat Cancer. 2012;19:R163-R185. [PMID: 22645227 DOI: 10.1530/erc-12-0024] [Cited by in Crossref: 82] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
191 Djukom C, Porro LJ, Mrazek A, Townsend CM Jr, Hellmich MR, Chao C. Dual inhibition of PI3K and mTOR signaling pathways decreases human pancreatic neuroendocrine tumor metastatic progression. Pancreas 2014;43:88-92. [PMID: 24263107 DOI: 10.1097/MPA.0b013e3182a44ab4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
192 Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V, Meyer T, Newell-Price J, Poston G, Reed N, Rockall A, Steward W, Thakker RV, Toubanakis C, Valle J, Verbeke C, Grossman AB;  UK and Ireland Neuroendocrine Tumour Society. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012;61:6-32. [PMID: 22052063 DOI: 10.1136/gutjnl-2011-300831] [Cited by in Crossref: 353] [Cited by in F6Publishing: 280] [Article Influence: 32.1] [Reference Citation Analysis]
193 Chu LC, Johnson PT, Fishman EK. Cinematic rendering of pancreatic neoplasms: preliminary observations and opportunities. Abdom Radiol 2018;43:3009-15. [DOI: 10.1007/s00261-018-1559-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
194 Ellison EC, Johnson JA. The Zollinger-Ellison syndrome: a comprehensive review of historical, scientific, and clinical considerations. Curr Probl Surg. 2009;46:13-106. [PMID: 19059523 DOI: 10.1067/j.cpsurg.2008.09.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 4.5] [Reference Citation Analysis]
195 Assumpcao L, Choti M, Pawlik TM, Gecshwind J, Kamel IR. Functional MR imaging as a new paradigm for image guidance. Abdom Imaging 2009;34:675-85. [DOI: 10.1007/s00261-008-9481-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
196 Minter RM, Simeone DM. Contemporary Management of Nonfunctioning Pancreatic Neuroendocrine Tumors. J Gastrointest Surg 2012;16:435-46. [DOI: 10.1007/s11605-011-1693-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
197 Macedo D, Amaral T, Fernandes I, Sousa AR, Costa AL, Távora I, Quintela A, Cortes P, Costa L. The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012. ISRN Hepatol 2013;2013:702167. [PMID: 27335831 DOI: 10.1155/2013/702167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
198 Stoeltzing O, Loss M, Huber E, Gross V, Eilles C, Mueller-brand J, Schlitt HJ. Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. Langenbecks Arch Surg 2010;395:185-92. [DOI: 10.1007/s00423-009-0520-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
199 Barbier L, Turrini O, Sarran A, Delpero J. Pancreatic endocrine tumor with neoplastic venous thrombus and bilobar liver metastasis. A case report. Journal of Visceral Surgery 2010;147:e58-62. [DOI: 10.1016/j.jviscsurg.2010.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
200 Chan JA, Kulke MH. Emerging therapies for the treatment of patients with advanced neuroendocrine tumors. Expert Opin Emerg Drugs 2007;12:253-70. [PMID: 17604500 DOI: 10.1517/14728214.12.2.253] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
201 Bernheim AM, Connolly HM, Rubin J, Møller JE, Scott CG, Nagorney DM, Pellikka PA. Role of hepatic resection for patients with carcinoid heart disease. Mayo Clin Proc 2008;83:143-50. [PMID: 18241623 DOI: 10.4065/83.2.143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
202 Lesurtel M, Nagorney DM, Mazzaferro V, Jensen RT, Poston GJ. When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations. HPB (Oxford). 2015;17:17-22. [PMID: 24636662 DOI: 10.1111/hpb.12225] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
203 Fiore F, Del Prete M, Franco R, Marotta V, Ramundo V, Marciello F, Di Sarno A, Carratù AC, de Luca di Roseto C, Colao A, Faggiano A. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors. Endocrine 2014;47:177-82. [DOI: 10.1007/s12020-013-0130-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 8.1] [Reference Citation Analysis]
204 Doi R. Determinants of surgical resection for pancreatic neuroendocrine tumors. J Hepatobiliary Pancreat Sci. 2015;22:610-617. [PMID: 25773163 DOI: 10.1002/jhbp.224] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
205 Kimura W, Tezuka K, Hirai I. Surgical management of pancreatic neuroendocrine tumors. Surg Today. 2011;41:1332-1343. [PMID: 21922354 DOI: 10.1007/s00595-011-4547-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
206 Birnbaum DJ, Turrini O, Vigano L, Russolillo N, Autret A, Moutardier V, Capussotti L, Le Treut YP, Delpero JR, Hardwigsen J. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study. Ann Surg Oncol. 2015;22:1000-1007. [PMID: 25190116 DOI: 10.1245/s10434-014-4016-8] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
207 Yuan CH, Wang J, Xiu DR, Tao M, Ma ZL, Jiang B, Li ZF, Li L, Wang L, Wang H. Meta-analysis of Liver Resection Versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases. Ann Surg Oncol. 2016;23:244-249. [PMID: 26111625 DOI: 10.1245/s10434-015-4654-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
208 Chouliaras K, Newman NA, Shukla M, Swett KR, Levine EA, Sham J, Mann GN, Shen P. Analysis of recurrence after the resection of pancreatic neuroendocrine tumors. J Surg Oncol 2018;118:416-21. [PMID: 30259518 DOI: 10.1002/jso.25146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
209 Reddy SK, Clary BM. Neuroendocrine liver metastases. Surg Clin North Am. 2010;90:853-861. [PMID: 20637952 DOI: 10.1016/j.suc.2010.04.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
210 Naumann M, Bonsall R, Gupta R. Chemoembolization with drug-eluting beads complicated by intrahepatic biloma. Semin Intervent Radiol 2011;28:212-7. [PMID: 22654265 DOI: 10.1055/s-0031-1280667] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
211 Pavel M, Baudin E, Couvelard A, Krenning E, Öberg K, Steinmüller T, Anlauf M, Wiedenmann B, Salazar R; Barcelona Consensus Conference participants. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012;95:157-176. [PMID: 22262022 DOI: 10.1159/000335597] [Cited by in Crossref: 525] [Cited by in F6Publishing: 425] [Article Influence: 52.5] [Reference Citation Analysis]
212 Reidy DL, Tang LH, Saltz LB. Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors. Nat Clin Pract Oncol. 2009;6:143-152. [PMID: 19190591 DOI: 10.1038/ncponc1326] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
213 Fendrich V, Waldmann J, Bartsch DK, Langer P. Surgical management of pancreatic endocrine tumors. Nat Rev Clin Oncol 2009;6:419-28. [DOI: 10.1038/nrclinonc.2009.82] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 6.2] [Reference Citation Analysis]
214 Bartók Á, Banai Z, Berczi L. [The surgical case of a 34-year-old female patient with a metastatizing double colon tumor with different histological structure, causing mechanical obstruction]. Magy Seb 2014;67:44-7. [PMID: 24747403 DOI: 10.1556/MaSeb.67.2014.2.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
215 Fernandez R, Pappas SG, Bentrem DJ. Clinical Features of Metastatic Hepatic Malignancies. Cancer Treat Res 2016;168:185-202. [PMID: 29206370 DOI: 10.1007/978-3-319-34244-3_9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
216 Falconi M, Zerbi A, Crippa S, Balzano G, Boninsegna L, Capitanio V, Bassi C, Di Carlo V, Pederzoli P. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol. 2010;17:1621-1627. [PMID: 20162460 DOI: 10.1155/2012/782672] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
217 Perri G, Prakash LR, Katz MHG. Pancreatic neuroendocrine tumors. Curr Opin Gastroenterol 2019;35:468-77. [PMID: 31306159 DOI: 10.1097/MOG.0000000000000571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
218 Landry CS, Scoggins CR, McMasters KM, Martin RC 2nd. Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol. 2008;97:253-258. [PMID: 18264984 DOI: 10.1002/jso.20957] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 4.0] [Reference Citation Analysis]
219 Sakuma Y, Sata N, Endo K, Yasuda Y, Yokota S, Hosoya Y, Shimizu A, Fujii H, Matsubara D, Fukushima N, Asakawa S, Shimada YK, Lefor CK, Lefor AK. An isolated metachronous metastasis to the adrenal gland from a pancreatic neuroendocrine tumor: A case report. Int J Surg Case Rep 2017;41:169-73. [PMID: 29102861 DOI: 10.1016/j.ijscr.2017.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
220 Cloyd JM, Poultsides GA. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management. World J Gastroenterol 2015; 21(32): 9512-9525 [PMID: 26327759 DOI: 10.3748/wjg.v21.i32.9512] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 56] [Article Influence: 9.0] [Reference Citation Analysis]